| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 23 | 2024 | 30 | 8.340 |
Why?
|
| TRPC Cation Channels | 15 | 2023 | 15 | 4.670 |
Why?
|
| TRPC6 Cation Channel | 20 | 2024 | 20 | 4.540 |
Why?
|
| Signal Transduction | 15 | 2024 | 216 | 2.670 |
Why?
|
| Animals | 49 | 2024 | 1711 | 2.630 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 6 | 2023 | 7 | 2.410 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 8 | 2024 | 8 | 2.360 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 4 | 2024 | 4 | 2.230 |
Why?
|
| Mice | 26 | 2024 | 685 | 2.120 |
Why?
|
| Potassium Channels, Calcium-Activated | 10 | 2007 | 10 | 1.970 |
Why?
|
| Kidney | 7 | 2021 | 51 | 1.610 |
Why?
|
| Gene Expression Regulation | 6 | 2018 | 73 | 1.580 |
Why?
|
| Nephrosis | 3 | 2024 | 3 | 1.570 |
Why?
|
| Ion Channel Gating | 11 | 2013 | 12 | 1.400 |
Why?
|
| Membrane Proteins | 8 | 2017 | 47 | 1.380 |
Why?
|
| Cell Line | 14 | 2021 | 84 | 1.340 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2024 | 125 | 1.240 |
Why?
|
| Diabetic Nephropathies | 4 | 2023 | 5 | 1.200 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2016 | 10 | 1.190 |
Why?
|
| Rats | 9 | 2024 | 241 | 1.140 |
Why?
|
| Reactive Oxygen Species | 6 | 2024 | 30 | 1.140 |
Why?
|
| Kidney Diseases | 3 | 2022 | 10 | 1.110 |
Why?
|
| Ganglia, Parasympathetic | 5 | 2005 | 5 | 1.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2017 | 12 | 1.050 |
Why?
|
| Actins | 6 | 2014 | 23 | 1.040 |
Why?
|
| Neurons | 6 | 2005 | 109 | 1.010 |
Why?
|
| Circadian Rhythm | 7 | 2007 | 34 | 1.010 |
Why?
|
| Cell Membrane | 6 | 2016 | 48 | 1.000 |
Why?
|
| STAT3 Transcription Factor | 3 | 2015 | 5 | 0.980 |
Why?
|
| Receptor for Advanced Glycation End Products | 2 | 2024 | 4 | 0.910 |
Why?
|
| Humans | 22 | 2022 | 4936 | 0.900 |
Why?
|
| Retinal Cone Photoreceptor Cells | 4 | 2007 | 35 | 0.870 |
Why?
|
| Cells, Cultured | 14 | 2014 | 127 | 0.870 |
Why?
|
| Kidney Glomerulus | 4 | 2022 | 10 | 0.850 |
Why?
|
| Chick Embryo | 13 | 2007 | 13 | 0.850 |
Why?
|
| Angiotensin II | 2 | 2014 | 13 | 0.840 |
Why?
|
| beta-Arrestin 1 | 1 | 2024 | 1 | 0.840 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2024 | 1 | 0.840 |
Why?
|
| Integrin alphaVbeta3 | 2 | 2021 | 4 | 0.830 |
Why?
|
| Protein Subunits | 4 | 2024 | 7 | 0.830 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 14 | 0.810 |
Why?
|
| Albuminuria | 2 | 2022 | 2 | 0.780 |
Why?
|
| NADPH Oxidase 2 | 3 | 2018 | 5 | 0.770 |
Why?
|
| Channelopathies | 1 | 2022 | 1 | 0.760 |
Why?
|
| Mesangial Cells | 2 | 2019 | 2 | 0.720 |
Why?
|
| Microfilament Proteins | 3 | 2016 | 16 | 0.700 |
Why?
|
| Calcium | 6 | 2024 | 31 | 0.630 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 5 | 2024 | 5 | 0.630 |
Why?
|
| Nephrotic Syndrome | 2 | 2017 | 3 | 0.630 |
Why?
|
| Ion Channels | 3 | 2004 | 5 | 0.630 |
Why?
|
| src-Family Kinases | 2 | 2018 | 3 | 0.620 |
Why?
|
| Aging | 1 | 2021 | 109 | 0.620 |
Why?
|
| Membrane Potentials | 8 | 2010 | 16 | 0.610 |
Why?
|
| Patch-Clamp Techniques | 11 | 2007 | 18 | 0.610 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 4 | 0.600 |
Why?
|
| Motor Neurons | 3 | 2004 | 13 | 0.580 |
Why?
|
| Dizocilpine Maleate | 2 | 2016 | 3 | 0.580 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 23 | 0.570 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 7 | 0.560 |
Why?
|
| Gene Silencing | 1 | 2018 | 6 | 0.560 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17 | 0.560 |
Why?
|
| Transforming Growth Factor beta | 5 | 2005 | 10 | 0.550 |
Why?
|
| Serum | 1 | 2017 | 5 | 0.530 |
Why?
|
| Plasma | 1 | 2017 | 6 | 0.530 |
Why?
|
| Gene Expression | 2 | 2007 | 49 | 0.510 |
Why?
|
| Diglycerides | 2 | 2013 | 6 | 0.500 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 4 | 0.500 |
Why?
|
| NADPH Oxidases | 2 | 2013 | 4 | 0.500 |
Why?
|
| Memantine | 1 | 2016 | 1 | 0.500 |
Why?
|
| Calcium Channels, L-Type | 2 | 2007 | 2 | 0.490 |
Why?
|
| NFATC Transcription Factors | 2 | 2015 | 12 | 0.480 |
Why?
|
| Disease Models, Animal | 4 | 2022 | 225 | 0.480 |
Why?
|
| Integrin alphaV | 1 | 2015 | 1 | 0.460 |
Why?
|
| Syndecan-4 | 1 | 2015 | 1 | 0.460 |
Why?
|
| Receptors, Glutamate | 1 | 2015 | 3 | 0.450 |
Why?
|
| Glutamic Acid | 1 | 2015 | 5 | 0.450 |
Why?
|
| Synaptophysin | 1 | 2014 | 1 | 0.440 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2015 | 4 | 0.440 |
Why?
|
| Cyclic AMP | 2 | 2004 | 11 | 0.430 |
Why?
|
| N-Methylaspartate | 2 | 2012 | 9 | 0.420 |
Why?
|
| ras Proteins | 2 | 2004 | 3 | 0.410 |
Why?
|
| Potassium Channels | 3 | 2006 | 3 | 0.390 |
Why?
|
| Nerve Growth Factors | 2 | 2003 | 5 | 0.390 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 3 | 2007 | 5 | 0.380 |
Why?
|
| Cyclic GMP | 3 | 2007 | 6 | 0.380 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 32 | 0.370 |
Why?
|
| Apoptosis | 1 | 2012 | 46 | 0.370 |
Why?
|
| Time Factors | 6 | 2011 | 163 | 0.370 |
Why?
|
| Oxidative Stress | 1 | 2012 | 58 | 0.350 |
Why?
|
| Glucose | 1 | 2011 | 13 | 0.350 |
Why?
|
| Insulin | 1 | 2011 | 29 | 0.350 |
Why?
|
| Puromycin Aminonucleoside | 2 | 2024 | 2 | 0.340 |
Why?
|
| Male | 5 | 2024 | 2491 | 0.330 |
Why?
|
| Phosphorylation | 5 | 2014 | 48 | 0.330 |
Why?
|
| Light | 2 | 2007 | 43 | 0.320 |
Why?
|
| Spinal Cord | 3 | 2004 | 9 | 0.310 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2009 | 17 | 0.310 |
Why?
|
| Enzyme Inhibitors | 6 | 2005 | 33 | 0.310 |
Why?
|
| Mice, Knockout | 4 | 2023 | 140 | 0.300 |
Why?
|
| Transfection | 5 | 2007 | 15 | 0.300 |
Why?
|
| Cell Line, Transformed | 3 | 2017 | 6 | 0.300 |
Why?
|
| Protein Binding | 4 | 2013 | 115 | 0.300 |
Why?
|
| Glomerular Filtration Barrier | 2 | 2022 | 2 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 9 | 0.290 |
Why?
|
| Light Signal Transduction | 2 | 2007 | 2 | 0.290 |
Why?
|
| Mutation | 3 | 2019 | 132 | 0.290 |
Why?
|
| Neuregulin-1 | 2 | 2005 | 2 | 0.280 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2011 | 8 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2011 | 14 | 0.270 |
Why?
|
| Somatostatin-28 | 1 | 2007 | 1 | 0.270 |
Why?
|
| Lighting | 1 | 2007 | 9 | 0.270 |
Why?
|
| Contractile Proteins | 1 | 2007 | 1 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 9 | 0.270 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2007 | 1 | 0.260 |
Why?
|
| Protein Transport | 4 | 2011 | 30 | 0.240 |
Why?
|
| Green Fluorescent Proteins | 4 | 2007 | 22 | 0.240 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 3 | 0.230 |
Why?
|
| Neural Inhibition | 1 | 2005 | 5 | 0.230 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2005 | 2 | 0.230 |
Why?
|
| Biological Transport | 1 | 2005 | 18 | 0.230 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2011 | 7 | 0.230 |
Why?
|
| Growth Substances | 1 | 2004 | 1 | 0.220 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2009 | 3 | 0.210 |
Why?
|
| Integrin alpha5 | 1 | 2024 | 1 | 0.210 |
Why?
|
| Integrin beta3 | 1 | 2024 | 3 | 0.210 |
Why?
|
| Imidazoles | 2 | 2014 | 15 | 0.210 |
Why?
|
| Methionine | 1 | 2003 | 2 | 0.200 |
Why?
|
| RNA Interference | 2 | 2014 | 23 | 0.200 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2003 | 5 | 0.200 |
Why?
|
| Dopamine Agonists | 1 | 2003 | 9 | 0.200 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2023 | 1 | 0.200 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2023 | 1 | 0.200 |
Why?
|
| Dopamine | 1 | 2003 | 26 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 52 | 0.190 |
Why?
|
| Biotinylation | 3 | 2007 | 15 | 0.190 |
Why?
|
| Nephritis, Interstitial | 1 | 2022 | 1 | 0.190 |
Why?
|
| Albumins | 1 | 2022 | 4 | 0.190 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 47 | 0.190 |
Why?
|
| Fibrosis | 1 | 2021 | 12 | 0.170 |
Why?
|
| Drug Interactions | 3 | 2005 | 8 | 0.170 |
Why?
|
| Proteinuria | 2 | 2023 | 10 | 0.170 |
Why?
|
| Biomarkers | 1 | 2021 | 81 | 0.170 |
Why?
|
| Inflammation | 1 | 2021 | 57 | 0.170 |
Why?
|
| Enzyme Activation | 3 | 2004 | 13 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 30 | 0.160 |
Why?
|
| Adult | 2 | 2017 | 1567 | 0.160 |
Why?
|
| Electrophysiology | 5 | 2007 | 24 | 0.160 |
Why?
|
| Calcium Channel Blockers | 2 | 2013 | 4 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 3 | 0.150 |
Why?
|
| Glomerulonephritis | 1 | 2019 | 6 | 0.150 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 2 | 2011 | 2 | 0.150 |
Why?
|
| Spin Labels | 1 | 2018 | 7 | 0.140 |
Why?
|
| Hydrogen Peroxide | 1 | 2018 | 5 | 0.140 |
Why?
|
| Cyclic N-Oxides | 1 | 2018 | 7 | 0.140 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 1 | 0.140 |
Why?
|
| Gene Targeting | 1 | 2018 | 3 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 10 | 0.140 |
Why?
|
| Alleles | 1 | 2018 | 16 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 9 | 0.140 |
Why?
|
| Peptides | 2 | 2013 | 49 | 0.140 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 51 | 0.140 |
Why?
|
| Permeability | 1 | 2017 | 14 | 0.130 |
Why?
|
| Kidney Tubules | 1 | 2016 | 5 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2016 | 7 | 0.120 |
Why?
|
| Female | 5 | 2017 | 2523 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 14 | 0.120 |
Why?
|
| Body Weight | 1 | 2016 | 58 | 0.120 |
Why?
|
| Second Messenger Systems | 1 | 2016 | 4 | 0.120 |
Why?
|
| Biological Clocks | 3 | 2005 | 9 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 1 | 0.120 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2015 | 2 | 0.120 |
Why?
|
| Neuropeptides | 1 | 2015 | 3 | 0.120 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2015 | 4 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 7 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2015 | 3 | 0.110 |
Why?
|
| Colchicine | 2 | 2005 | 2 | 0.110 |
Why?
|
| Nocodazole | 2 | 2005 | 2 | 0.110 |
Why?
|
| Smell | 2 | 2005 | 6 | 0.110 |
Why?
|
| Calcineurin | 1 | 2014 | 11 | 0.110 |
Why?
|
| Cell Movement | 1 | 2014 | 61 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2004 | 3 | 0.110 |
Why?
|
| Receptors, Angiotensin | 1 | 2014 | 4 | 0.110 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2005 | 4 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2005 | 8 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2014 | 16 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2014 | 17 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 19 | 0.100 |
Why?
|
| Polyunsaturated Alkamides | 2 | 2004 | 2 | 0.100 |
Why?
|
| Evoked Potentials | 1 | 2014 | 21 | 0.100 |
Why?
|
| Polyenes | 2 | 2004 | 4 | 0.100 |
Why?
|
| Darkness | 2 | 2004 | 4 | 0.100 |
Why?
|
| CHO Cells | 1 | 2013 | 17 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2004 | 39 | 0.100 |
Why?
|
| Cricetinae | 1 | 2013 | 21 | 0.100 |
Why?
|
| Cricetulus | 1 | 2013 | 18 | 0.100 |
Why?
|
| Chlorobenzoates | 1 | 2013 | 1 | 0.100 |
Why?
|
| Estrenes | 1 | 2013 | 1 | 0.100 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 1 | 0.100 |
Why?
|
| Spider Venoms | 1 | 2013 | 1 | 0.100 |
Why?
|
| Thionucleotides | 1 | 2013 | 1 | 0.100 |
Why?
|
| Cytochalasin D | 1 | 2013 | 1 | 0.100 |
Why?
|
| ortho-Aminobenzoates | 1 | 2013 | 1 | 0.100 |
Why?
|
| Phospholipase A2 Inhibitors | 1 | 2013 | 1 | 0.100 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2013 | 2 | 0.100 |
Why?
|
| Type C Phospholipases | 1 | 2013 | 2 | 0.100 |
Why?
|
| Guanosine Diphosphate | 1 | 2013 | 2 | 0.100 |
Why?
|
| Cinnamates | 1 | 2013 | 3 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 3 | 0.100 |
Why?
|
| Drosophila | 2 | 2004 | 25 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2013 | 30 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 35 | 0.100 |
Why?
|
| Doxorubicin | 2 | 2023 | 5 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2012 | 1 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 3 | 0.090 |
Why?
|
| Lumbosacral Region | 2 | 2002 | 2 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2012 | 16 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2011 | 22 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 160 | 0.080 |
Why?
|
| Actin Cytoskeleton | 1 | 2010 | 11 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 24 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 6 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2010 | 5 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2010 | 8 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 96 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2007 | 70 | 0.080 |
Why?
|
| Ion Transport | 2 | 2016 | 3 | 0.080 |
Why?
|
| Cytosol | 1 | 2008 | 7 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2008 | 11 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2006 | 15 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2023 | 66 | 0.070 |
Why?
|
| Plasmids | 2 | 2005 | 19 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2008 | 13 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2006 | 17 | 0.070 |
Why?
|
| Chickens | 1 | 2008 | 22 | 0.070 |
Why?
|
| Receptors, Somatostatin | 1 | 2007 | 1 | 0.070 |
Why?
|
| Binding Sites | 1 | 2007 | 66 | 0.070 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 1 | 0.070 |
Why?
|
| Hemagglutinins | 1 | 2007 | 1 | 0.070 |
Why?
|
| Filamins | 1 | 2007 | 1 | 0.070 |
Why?
|
| Precipitin Tests | 1 | 2007 | 3 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 9 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 4 | 0.070 |
Why?
|
| Melanoma | 1 | 2007 | 28 | 0.060 |
Why?
|
| Photic Stimulation | 1 | 2007 | 136 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2004 | 18 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 25 | 0.060 |
Why?
|
| Cerebral Arteries | 1 | 2006 | 1 | 0.060 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2005 | 1 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 5 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 6 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 9 | 0.060 |
Why?
|
| Electric Stimulation | 1 | 2005 | 21 | 0.060 |
Why?
|
| Brefeldin A | 1 | 2005 | 1 | 0.060 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2005 | 1 | 0.060 |
Why?
|
| Boron Compounds | 1 | 2005 | 3 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2005 | 4 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 5 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2005 | 7 | 0.060 |
Why?
|
| Age Factors | 1 | 2005 | 65 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 49 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 9 | 0.060 |
Why?
|
| Colforsin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Nitrendipine | 1 | 2004 | 2 | 0.060 |
Why?
|
| Axonal Transport | 1 | 2004 | 1 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2004 | 3 | 0.050 |
Why?
|
| Neurons, Afferent | 1 | 2004 | 1 | 0.050 |
Why?
|
| Biolistics | 1 | 2004 | 1 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2004 | 1 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2004 | 2 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 12 | 0.050 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2003 | 1 | 0.050 |
Why?
|
| Farnesyltranstransferase | 1 | 2003 | 1 | 0.050 |
Why?
|
| Smad2 Protein | 1 | 2003 | 1 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 22 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2003 | 1 | 0.050 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2003 | 1 | 0.050 |
Why?
|
| Dopamine Antagonists | 1 | 2003 | 5 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2003 | 5 | 0.050 |
Why?
|
| Sodium | 1 | 2003 | 12 | 0.050 |
Why?
|
| Capsaicin | 1 | 2023 | 2 | 0.050 |
Why?
|
| Synapses | 1 | 2003 | 10 | 0.050 |
Why?
|
| Immune Sera | 1 | 2002 | 1 | 0.050 |
Why?
|
| Calcium Channels | 1 | 2002 | 1 | 0.050 |
Why?
|
| Neurotrophin 3 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2002 | 1 | 0.050 |
Why?
|
| Cell Extracts | 1 | 2002 | 2 | 0.050 |
Why?
|
| Hindlimb | 1 | 2002 | 4 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2002 | 8 | 0.050 |
Why?
|
| Aryldialkylphosphatase | 1 | 2022 | 1 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2002 | 9 | 0.050 |
Why?
|
| Nerve Net | 1 | 2003 | 25 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2002 | 19 | 0.050 |
Why?
|
| Androstadienes | 1 | 2002 | 1 | 0.050 |
Why?
|
| Chromones | 1 | 2002 | 1 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 2 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 3 | 0.050 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2002 | 3 | 0.050 |
Why?
|
| Morpholines | 1 | 2002 | 3 | 0.050 |
Why?
|
| Lipids | 1 | 2022 | 20 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 24 | 0.050 |
Why?
|
| Flavonoids | 1 | 2002 | 20 | 0.050 |
Why?
|
| Apamin | 1 | 2002 | 1 | 0.050 |
Why?
|
| Tubocurarine | 1 | 2002 | 1 | 0.050 |
Why?
|
| Nicotinic Antagonists | 1 | 2002 | 1 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2002 | 2 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2002 | 9 | 0.050 |
Why?
|
| Retina | 1 | 2003 | 130 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 78 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2011 | 68 | 0.030 |
Why?
|
| Glomerular Mesangium | 1 | 2015 | 1 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 184 | 0.030 |
Why?
|
| CLOCK Proteins | 2 | 2004 | 5 | 0.030 |
Why?
|
| Feedback | 2 | 2004 | 31 | 0.030 |
Why?
|
| Drosophila Proteins | 2 | 2004 | 30 | 0.020 |
Why?
|
| Half-Life | 1 | 2011 | 9 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 36 | 0.020 |
Why?
|
| Estrogens | 1 | 2011 | 21 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 55 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 115 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2006 | 1 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2006 | 2 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 16 | 0.020 |
Why?
|
| Vasodilation | 1 | 2006 | 7 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 19 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 23 | 0.010 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2005 | 1 | 0.010 |
Why?
|
| Sensory Receptor Cells | 1 | 2005 | 2 | 0.010 |
Why?
|
| Odorants | 1 | 2004 | 1 | 0.010 |
Why?
|
| ARNTL Transcription Factors | 1 | 2004 | 1 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 2 | 0.010 |
Why?
|
| Transgenes | 1 | 2004 | 6 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 12 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 15 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2005 | 45 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 12 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 61 | 0.010 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2003 | 1 | 0.010 |
Why?
|
| Cryptochromes | 1 | 2003 | 1 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2003 | 5 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2003 | 8 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 14 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2003 | 14 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 29 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2003 | 36 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 124 | 0.010 |
Why?
|